Arena Optimistic About Lorcaserin But Analysts More Reserved
This article was originally published in The Pink Sheet Daily
Executive Summary
Arena Pharmaceuticals argues it has the necessary safety data to convince an FDA advisory committee to recommend approval of its key drug, a weight loss treatment.